SS31 10mg Research Peptide
SS31 (Elamipretide) is a synthetic mitochondria-targeted peptide commonly utilized in laboratory research involving mitochondrial biology, cellular signaling pathways, and bioenergetic processes. Researchers investigate SS31 in experimental models examining cellular communication, mitochondrial function, and peptide-mediated biological mechanisms.
This product is intended strictly for laboratory research purposes, not for human consumption, therapeutic use, veterinary use, or diagnostic use.
Specifications
| Compound | SS-31 10mg |
|---|---|
| Category | Peptide |
| SKU | GRL-SS31-10MG |
| Unit size | 10 mg |
| Price | $50.00 |
| Availability | In stock |
| Intended use | Laboratory research use only |
Compound identity
Reference facts for the compound itself, from PubChem (NIH). They describe the molecule, not a specific batch — batch purity is reported on the certificate of analysis.
| CAS Registry Number | 736992-21-5 |
|---|---|
| Molecular formula | C32H49N9O5 |
| Molecular weight | 639.8 g/mol |
| PubChem name | Elamipretide |
| PubChem CID | 11764719 |
SS-31 10mg is also written SS-31, SS-31 peptide, SS31, SS31 peptide and SS 31.
Research Applications
- Mitochondrial function research
- Cellular signaling studies
- Bioenergetic pathways investigations
- Peptide interaction research
- Laboratory-based biological studies
Product Specifications
- Contents: SS31 (Elamipretide)
- Quantity: 10mg per vial
- Appearance: Lyophilized powder
- Storage: Refrigerate upon receipt
- Research Use Only
Research questions about this compound
How does SS-31 interact with cardiolipin?
Research indicates that SS-31 binds to cardiolipin in the inner mitochondrial membrane, which helps to stabilize the structure of the membrane and prevents the peroxidase activity of cytochrome c . This is a mechanism-only finding observed in laboratory settings .
Has SS-31 been approved by the FDA?
Yes, the FDA granted accelerated approval to elamipretide (SS-31) for the treatment of Barth syndrome in patients aged 12 years and older . This approval is specific to that defined patient population .
What did the ReCLAIM-2 trial show?
The ReCLAIM-2 phase 2 trial evaluated the use of SS-31 in patients with geographic atrophy associated with dry AMD . The study gathered data on the progression of the condition, contributing to the clinical evidence base for the compound in ocular research .
Did SS-31 improve exercise capacity in mitochondrial myopathy?
In a randomized, placebo-controlled trial involving patients with primary mitochondrial myopathy, the peptide did not demonstrate a statistically significant improvement in the 6-minute walk distance compared to the placebo .
labels, lab notebooks, reorders
SS-31 10mg — Reconstitution Calculator
For laboratory research use only. This tool computes the concentration of a reconstituted research solution and the volume that contains a target mass. Vial mass is a product specification, not a dose. It is not medical guidance and does not describe administration to humans or animals.
For laboratory research use only · not for human or animal use. Doses-per-bottle is pure arithmetic (vial mass ÷ target amount), not a dosing recommendation.
